XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Change in Accounting Estimate [Line Items]          
Capital resources $ 241,000 $ 241,000      
Net income (loss)   21,133 $ (43,977) $ (192,300) $ (178,300)
Accumulated deficit 1,127,412 1,127,412   $ 1,148,545  
Letter of credit established as a deposit 1,500 $ 1,500      
Kite Pharma, Inc.          
Change in Accounting Estimate [Line Items]          
Change in estimate of transaction price, increase in revenue 8,900        
Increase in net income $ 8,900        
Increased earnings per share, basic (in dollars per share) $ 0.06        
Increased earnings per share, diluted (in dollars per share) $ 0.05